{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:44:00Z","timestamp":1787499840923,"version":"build-2736575974"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome characterized by abnormalities in hepatic fat deposition, the incidence of which has been increasing year by year in recent years. It has become the largest chronic liver disease globally and one of the important causes of cirrhosis and even primary liver cancer formation. The pathogenesis of NAFLD has not yet been fully clarified. Modern medicine lacks targeted clinical treatment protocols for NAFLD, and most drugs lack efficacy and have high side effects. In contrast, Traditional Chinese Medicine (TCM) has significant advantages in the treatment and prevention of NAFLD, which have been widely recognized by scholars around the world. In recent years, through the establishment of a \u201cmedicine-disease-target-pathway\u201d network relationship, network pharmacology can explore the molecular basis of the role of medicines in disease prevention and treatment from various perspectives, predicting the pharmacological mechanism of the corresponding medicines. This approach is compatible with the holistic view and treatment based on pattern differentiation of TCM and has been widely used in TCM research. In this paper, by searching relevant databases such as PubMed, Web of Science, and Embase, we reviewed and analyzed the relevant signaling pathways and specific mechanisms of action of single Chinese medicine, Chinese medicine combinations, and Chinese patent medicine for the treatment of NAFLD in recent years. These related studies fully demonstrated the therapeutic characteristics of TCM with multi-components, multi-targets, and multi-pathways, which provided strong support for the exact efficacy of TCM exerted in the clinic. In conclusion, we believe that network pharmacology is more in line with the TCM mindset of treating diseases, but with some limitations. In the future, we should eliminate the potential risks of false positives and false negatives, clarify the interconnectivity between components, targets, and diseases, and conduct deeper clinical or experimental studies.<\/jats:p>","DOI":"10.3389\/fphar.2024.1381712","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:38:56Z","timestamp":1713314336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review"],"prefix":"10.3389","volume":"15","author":[{"given":"Shihao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Size","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ptr.6171","article-title":"Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases","volume":"32","author":"Abenavoli","year":"2018","journal-title":"Phytother. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1417","DOI":"10.1002\/wsbm.1417","article-title":"PharmGKB: a worldwide resource for pharmacogenomic information","volume":"10","author":"Barbarino","year":"2018","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5152\/tjg.2014.7675","article-title":"Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management","volume":"25","author":"Ba\u015farano\u011flu","year":"2014","journal-title":"Turk J. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jep.2016.07.080","article-title":"Network ethnopharmacological evaluation of the immunomodulatory activity of Withania somnifera","volume":"197","author":"Chandran","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"153685","DOI":"10.1016\/j.phymed.2021.153685","article-title":"Investigating the medicinal potential, material basis and mechanism of Polygoni Orientalis Fructus based on multi-technology integrated network pharmacology","volume":"91","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jgr.2017.10.003","article-title":"Ameliorative effect of black ginseng extract against oxidative stress-induced cellular damages in mouse hepatocytes","volume":"43","author":"Choudhry","year":"2019","journal-title":"J. Ginseng Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","article-title":"Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide","volume":"59","author":"Dai","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"117320","DOI":"10.1016\/j.jep.2023.117320","article-title":"Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signaling","volume":"319","author":"Deng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.3892\/mmr.2017.6880","article-title":"Cassiae semen: a review of its phytochemistry and pharmacology (Review)","volume":"16","author":"Dong","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/nu14030597","article-title":"Saffron (crocus sativus L.): a source of nutrients for health and for the treatment of neuropsychiatric and age-related diseases","volume":"14","author":"El Midaoui","year":"2022","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1021\/jm049838d","article-title":"CHMIS-C: a comprehensive herbal medicine information system for cancer","volume":"48","author":"Fang","year":"2005","journal-title":"J. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7251450","DOI":"10.1155\/2022\/7251450","article-title":"Pharmacological mechanism of ganlu powder in the treatment of NASH based on network pharmacology and molecular docking","volume":"2022","author":"Gao","year":"2022","journal-title":"Dis. Markers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1704960","DOI":"10.1155\/2020\/1704960","article-title":"Research on the mechanism of Qushi Huayu decoction in the intervention of nonalcoholic fatty liver disease based on network pharmacology and molecular docking technology","volume":"2020","author":"Gao","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"114603","DOI":"10.1016\/j.jep.2021.114603","article-title":"Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology","volume":"282","author":"Gong","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.19852\/j.cnki.jtcm.20231215.001","article-title":"Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification","volume":"44","author":"Guoguo","year":"2024","journal-title":"J. Tradit. Chin. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"D514","DOI":"10.1093\/nar\/gki033","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"33","author":"Hamosh","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ddr.21214","article-title":"Network pharmacology: a Rosetta Stone for traditional Chinese medicine","volume":"75","author":"Hao da","year":"2014","journal-title":"Drug Dev. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6588144","DOI":"10.1155\/2022\/6588144","article-title":"Exploring and verifying the mechanism and targets of shenqi pill in the treatment of nonalcoholic steatohepatitis via network pharmacology and experiments","volume":"2022","author":"He","year":"2022","journal-title":"J. Immunol. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jep.2013.11.023","article-title":"Eucommia ulmoides Oliv.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine","volume":"151","author":"He","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/molecules22040632","article-title":"A network-based pharmacology study of the herb-induced liver injury potential of traditional hepatoprotective Chinese herbal medicines","volume":"22","author":"Hong","year":"","journal-title":"Molecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/ijms18030620","article-title":"A biomedical investigation of the hepatoprotective effect of Radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets","volume":"18","author":"Hong","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/molecules22101617","article-title":"A network pharmacology-based study on the hepatoprotective effect of Fructus schisandrae","volume":"22","author":"Hong","year":"","journal-title":"Molecules"},{"key":"B26","doi-asserted-by":"publisher","first-page":"529553","DOI":"10.3389\/fphar.2020.529553","article-title":"The target MicroRNAs and potential underlying mechanisms of yiqi-bushen-tiaozhi recipe against-non-alcoholic steatohepatitis","volume":"11","author":"Hong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fphar.2019.00582","article-title":"Prediction of VEGF-C as a key target of pure total flavonoids from citrus against NAFLD in mice via network pharmacology","volume":"10","author":"Hong","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/molecules22040664","article-title":"Ameliorative effects and possible molecular mechanism of action of black ginseng (panax ginseng) on acetaminophen-mediated liver injury","volume":"22","author":"Hu","year":"2017","journal-title":"Molecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13040-020-00224-9","article-title":"Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease","volume":"13","author":"Hu","year":"2020","journal-title":"BioData Min."},{"key":"B32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"D1117","DOI":"10.1093\/nar\/gkx1028","article-title":"TCMID 2.0: a comprehensive resource for TCM","volume":"46","author":"Huang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20221375","article-title":"Exploring the mechanism of Cassiae semen in regulating lipid metabolism through network pharmacology and experimental validation","volume":"43","author":"Huang","year":"2023","journal-title":"Biosci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"7867245","DOI":"10.1155\/2020\/7867245","article-title":"A network-based approach to explore the mechanism and bioactive compounds of erzhi pill against metabolic dysfunction-associated fatty liver disease","volume":"2020","author":"Huang","year":"2020","journal-title":"J. Diabetes Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"111408","DOI":"10.1016\/j.biopha.2021.111408","article-title":"Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation","volume":"138","author":"Hung","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"154326","DOI":"10.1016\/j.phymed.2022.154326","article-title":"Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease","volume":"104","author":"Jia","year":"2022","journal-title":"Phytomedicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1080\/21655979.2022.2037374","article-title":"Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered"},{"key":"B41","doi-asserted-by":"publisher","first-page":"115965","DOI":"10.1016\/j.jep.2022.115965","article-title":"Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis","volume":"303","author":"Jiang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/pro.3711","article-title":"KEGG Mapper for inferring cellular functions from protein sequences","volume":"29","author":"Kanehisa","year":"2020","journal-title":"Protein Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.17925\/ee.2023.19.1.60","article-title":"Resmetirom: an orally administered, smallmolecule, liver-directed, \u03b2-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"19","author":"Karim","year":"2023","journal-title":"touchREV Endocrinol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"155835","DOI":"10.1016\/j.metabol.2024.155835","article-title":"Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges","volume":"154","author":"Kokkorakis","year":"2024","journal-title":"Metabolism"},{"key":"B46","doi-asserted-by":"publisher","first-page":"D684","DOI":"10.1093\/nar\/gkm795","article-title":"STITCH: interaction networks of chemicals and proteins","volume":"36","author":"Kuhn","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"155209","DOI":"10.1016\/j.phymed.2023.155209","article-title":"Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK\/p300\/SREBP-1c axis","volume":"123","author":"Lan","year":"2024","journal-title":"Phytomedicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"864703","DOI":"10.3389\/fendo.2022.864703","article-title":"Fufang Zhenzhu Tiaozhi capsule prevents intestinal inflammation and barrier disruption in mice with non-alcoholic steatohepatitis","volume":"13","author":"Lan","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B49","first-page":"820","article-title":"Antioxidative activity of water-soluble extracts from Fructus polygoni Orientalis","volume":"25","author":"Lei","year":"2005","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"B50","doi-asserted-by":"publisher","first-page":"115769","DOI":"10.1016\/j.jep.2022.115769","article-title":"Exploring the active compounds and potential mechanism of the anti-nonalcoholic fatty liver disease activity of the fraction from Schisandra chinensis fruit extract based on multi-technology integrated network pharmacology","volume":"301","author":"Li","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/s2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4196\/kjpp.2014.18.2.177","article-title":"Expression profile of neuro-endocrine-immune network in rats with vascular endothelial dysfunction","volume":"18","author":"Li","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.chmed.2021.05.001","article-title":"Investigating pharmacological mechanisms of andrographolide on non-alcoholic steatohepatitis (NASH): a bioinformatics approach of network pharmacology","volume":"13","author":"Li","year":"2021","journal-title":"Chin. Herb. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.21037\/atm-21-4809","article-title":"Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice","volume":"10","author":"Li","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"112029","DOI":"10.1016\/j.jep.2019.112029","article-title":"Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice","volume":"242","author":"Li","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/molecules23020352","article-title":"Hepatoprotective effects of a functional formula of three Chinese medicinal herbs: experimental evidence and network pharmacology-based identification of mechanism of action and potential bioactive components","volume":"23","author":"Li","year":"2018","journal-title":"Molecules"},{"key":"B57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s1875-5364(23)60429-7","article-title":"Network pharmacology approaches for research of Traditional Chinese Medicines","volume":"21","author":"Li","year":"","journal-title":"Chin. J. Nat. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11101-019-09655-7","article-title":"Lonicerae japonicae flos and Lonicerae flos: a systematic review of ethnopharmacology, phytochemistry and pharmacology","volume":"19","author":"Li","year":"2020","journal-title":"Phytochem. Rev."},{"key":"B59","first-page":"1387","article-title":"Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms","volume":"25","author":"Lin","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/ar.24770","article-title":"Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease","volume":"304","author":"Liu","year":"2021","journal-title":"Anat. Rec. Hob."},{"key":"B61","doi-asserted-by":"publisher","first-page":"115382","DOI":"10.1016\/j.jep.2022.115382","article-title":"Network pharmacology analysis on mechanism of Jian Pi Qing Gan Yin decoction ameliorating high fat diet-induced non-alcoholic fatty liver disease and validated in vivo","volume":"295","author":"Liu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1038\/srep21146","article-title":"BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"677659","DOI":"10.3389\/fnut.2021.677659","article-title":"Mechanism of Paeoniae Radix Alba in the treatment of non-alcoholic fatty liver disease based on sequential metabolites identification approach, network pharmacology, and binding affinity measurement","volume":"8","author":"Luo","year":"2021","journal-title":"Front. Nutr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1076569","DOI":"10.3389\/fnut.2023.1076569","article-title":"Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism","volume":"10","author":"Mao","year":"2023","journal-title":"Front. Nutr."},{"key":"B65","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1272214","DOI":"10.3389\/fendo.2023.1272214","article-title":"Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids","volume":"14","author":"Ni","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1111\/jcmm.15166","article-title":"A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors","volume":"24","author":"Nie","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1021\/jf400236x","article-title":"Characterization of a novel polysaccharide from tetraploid Gynostemma pentaphyllum makino","volume":"61","author":"Niu","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: curing causal mechanisms instead of treating symptoms","volume":"43","author":"Nogales","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"MASH clinical trials and drugs pipeline: an impending Tsunami","volume":"58","author":"Noureddin","year":"2024","journal-title":"Hepatology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4155\/fmc.14.8","article-title":"The ChEMBL database: a taster for medicinal chemists","volume":"6","author":"Papadatos","year":"2014","journal-title":"Future Med. Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5114\/aoms.2011.24129","article-title":"Protective effects of total glucosides of paeony and the underlying mechanisms in carbon tetrachloride-induced experimental liver injury","volume":"7","author":"Qin","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"B77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform"},{"key":"B78","first-page":"95","article-title":"Schisandra chinensis and its phytotherapeutical applications","volume":"68","author":"Rybnik\u00e1\u0159","year":"2019","journal-title":"Ceska Slov. Farm"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/ph15121477","article-title":"Eriodictyol suppresses gastric cancer cells via inhibition of PI3K\/AKT pathway","volume":"15","author":"Shan","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"},{"key":"B81","doi-asserted-by":"publisher","first-page":"115477","DOI":"10.1016\/j.jep.2022.115477","article-title":"Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation","volume":"296","author":"Shi","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jchromb.2013.12.004","article-title":"Preparative separation of polyphenols from the flowers of Paeonia lactiflora Pall. by high-speed counter-current chromatography","author":"Shu","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","article-title":"STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene","volume":"28","author":"Snel","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","article-title":"Use of molecular docking computational tools in drug discovery","volume":"60","author":"Stanzione","year":"2021","journal-title":"Prog. Med. Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"B86","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/molecules26206249","article-title":"Progress in the medicinal value, bioactive compounds, and pharmacological activities of gynostemma pentaphyllum","volume":"26","author":"Su","year":"2021","journal-title":"Molecules"},{"key":"B87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s41065-022-00256-7","article-title":"Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment","volume":"159","author":"Sun","year":"","journal-title":"Hereditas"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/medicina58091176","article-title":"Investigation of Lonicera japonica flos against nonalcoholic fatty liver disease using network integration and experimental validation","volume":"58","author":"Sun","year":"","journal-title":"Med. Kaunas."},{"key":"B89","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J. Hepatol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3748\/wjg.v27.i18.2160","article-title":"Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis","volume":"27","author":"Takayama","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"116418","DOI":"10.1016\/j.jep.2023.116418","article-title":"Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease","volume":"310","author":"Tan","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s2468-1253(24)00049-9","article-title":"Resmetirom for NASH: balancing promise and prudence","volume":"9","author":"The Lancet Gastroenterology","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4939-3743-1_2","article-title":"The gene ontology and the meaning of biological function","volume":"1446","author":"Thomas","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1039\/d3ra00458a","article-title":"Feruloylmonotropeins: promising natural antioxidants in Paederia scandens","volume":"13","author":"Trung","year":"2023","journal-title":"RSC Adv."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1111\/jcmm.17410","article-title":"Mechanisms of Gynostemma pentaphyllum against non-alcoholic fibre liver disease based on network pharmacology and molecular docking","volume":"26","author":"Wang","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.3390\/nu13114060","article-title":"Network pharmacology exploration reveals anti-apoptosis as a common therapeutic mechanism for non-alcoholic fatty liver disease treated with blueberry leaf polyphenols","volume":"13","author":"Wang","year":"","journal-title":"Nutrients"},{"key":"B99","doi-asserted-by":"publisher","first-page":"114056","DOI":"10.1016\/j.jep.2021.114056","article-title":"Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs","volume":"274","author":"Wang","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e27325","DOI":"10.1016\/j.heliyon.2024.e27325","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease: current status and future perspective","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"B101","doi-asserted-by":"publisher","first-page":"8829346","DOI":"10.1155\/2020\/8829346","article-title":"Identify molecular mechanisms of Jiangzhi decoction on nonalcoholic fatty liver disease by network pharmacology analysis and experimental validation","volume":"2020","author":"Wang","year":"","journal-title":"Biomed. Res. Int."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/jpp\/rgad067","article-title":"Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease","volume":"75","author":"Wang","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"14513","DOI":"10.1038\/s41598-017-15030-3","article-title":"Network-pharmacology-based validation of TAMS\/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"656115","DOI":"10.3389\/fphar.2021.656115","article-title":"Network pharmacological analysis and experimental validation of the mechanisms of action of Si-Ni-san against liver fibrosis","volume":"12","author":"Wang","year":"","journal-title":"Front. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"D1031","DOI":"10.1093\/nar\/gkz981","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"","journal-title":"Nucleic Acids Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e202200719","DOI":"10.1002\/cbdv.202200719","article-title":"Exploring the therapeutic effects of black ginseng on non-alcoholic fatty liver disease by using network pharmacology and molecular docking","volume":"19","author":"Wei","year":"2022","journal-title":"Chem. Biodivers."},{"key":"B107","doi-asserted-by":"publisher","first-page":"693701","DOI":"10.3389\/fphar.2021.693701","article-title":"Network pharmacology-based analysis on the potential biological mechanisms of sinisan against non-alcoholic fatty liver disease","volume":"12","author":"Wei","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1337373","DOI":"10.3389\/fmolb.2023.1337373","article-title":"Multi-omics approaches to studying gastrointestinal microbiome in the context of precision medicine and machine learning","volume":"10","author":"Wu","year":"","journal-title":"Front. Mol. Biosci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"722016","DOI":"10.3389\/fphar.2021.722016","article-title":"Integrating network pharmacology and RT-qPCR analysis to investigate the mechanisms underlying ZeXie decoction-mediated treatment of non-alcoholic fatty liver disease","volume":"12","author":"Wu","year":"","journal-title":"Front. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.biopha.2017.04.128","article-title":"Pure total flavonoids from citrus improve non-alcoholic fatty liver disease by regulating TLR\/CCL signaling pathway: a preliminary high-throughput \u2018omics\u2019 study","volume":"93","author":"Wu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.psj.2020.09.087","article-title":"Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken","volume":"100","author":"Wu","year":"","journal-title":"Poult. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/13880209.2023.2182892","article-title":"Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation","volume":"61","author":"Wu","year":"","journal-title":"Pharm. Biol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s1875-5364(19)30010-x","article-title":"Danshen: a phytochemical and pharmacological overview","volume":"17","author":"Xd","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20221030","article-title":"Exploring mechanisms of Chaihu-Shugan-San against liver fibrosis by integrated multi-omics and network pharmacology approach","volume":"42","author":"Xie","year":"2022","journal-title":"Biosci. Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"681391","DOI":"10.3389\/fmed.2021.681391","article-title":"Exploring the protective effects and mechanism of crocetin from saffron against NAFLD by network pharmacology and experimental validation","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1080\/13880209.2022.2106250","article-title":"Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease","volume":"60","author":"Xu","year":"2022","journal-title":"Pharm. Biol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"D1089","DOI":"10.1093\/nar\/gks1100","article-title":"TCMID: traditional Chinese Medicine integrative database for herb molecular mechanism analysis","volume":"41","author":"Xue","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"824597","DOI":"10.3389\/fcimb.2022.824597","article-title":"Yiqi-bushen-tiaozhi recipe attenuated high-fat and high-fructose diet induced nonalcoholic steatohepatitis in mice via gut microbiota","volume":"12","author":"Yan","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1248\/bpb.b20-00053","article-title":"Protective effect of fuzi lizhong decoction against non-alcoholic fatty liver disease via anti-inflammatory response through regulating p53 and PPARG signaling","volume":"43","author":"Yang","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"B121","doi-asserted-by":"publisher","first-page":"114759","DOI":"10.1016\/j.jep.2021.114759","article-title":"A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils","volume":"284","author":"Yang","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e14171","DOI":"10.7717\/peerj.14171","article-title":"Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation","volume":"10","author":"Yang","year":"","journal-title":"PeerJ"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1016745","DOI":"10.3389\/fphar.2022.1016745","article-title":"Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/1751-2980.12845","article-title":"Effects and therapeutic mechanism of Yinzhihuang on steatohepatitis in rats induced by a high-fat, high-cholesterol diet","volume":"21","author":"Zeng","year":"2020","journal-title":"J. Dig. Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3413186","DOI":"10.1155\/2020\/3413186","article-title":"Kangtaizhi granule alleviated nonalcoholic fatty liver disease in high-fat diet-fed rats and HepG2 cells via AMPK\/mTOR signaling pathway","volume":"2020","author":"Zhang","year":"","journal-title":"J. Immunol. Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"107248","DOI":"10.1016\/j.compbiolchem.2020.107248","article-title":"Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease","volume":"86","author":"Zhang","year":"","journal-title":"Comput. Biol. Chem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","article-title":"Network pharmacology databases for traditional Chinese medicine: review and assessment","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"115405","DOI":"10.1016\/j.jep.2022.115405","article-title":"Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation","volume":"296","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1082451","DOI":"10.3389\/fphar.2023.1082451","article-title":"Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification","volume":"14","author":"Zhi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"112181","DOI":"10.1016\/j.biopha.2021.112181","article-title":"Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF\/NF\u03baB signaling pathway-a study based on network pharmacology","volume":"143","author":"Zhou","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e25267","DOI":"10.1097\/md.0000000000025267","article-title":"Xiaochaihu decoction for nonalcoholic fatty liver disease: a protocol for a systematic review and meta-analysis","volume":"100","author":"Zhu","year":"2021","journal-title":"Med. Baltim."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1381712\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:39:07Z","timestamp":1713314347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1381712\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":131,"alternative-id":["10.3389\/fphar.2024.1381712"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1381712","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"article-number":"1381712"}}